Lab Manager | Run Your Lab Like a Business

White Papers and Application Notes

Gene therapy concept. Medical technology. Medtech.
photo provided by istock

Scale and Optimize Your Transfection in a Closed System

Flexible and scalable nonviral delivery for cGMP cell therapy processing

Closed manufacturing of cell therapies is widely accepted as an effective way to create a safer therapeutic product through reduction of error often associated with traditional manual cell processing techniques. In addition to closing manufacturing systems, the industry is moving toward targeted gene delivery methods such as transfection with CRISPR-Cas9 to achieve both performance and safety enhancements over traditional random integration of vectors.

Download the application note now to learn more about how to transform your current transfection step into one that’s closed, optimized, and scalable, courtesy of Thermo Fisher Scientific.